文献速递心外重症与机械循环支持冠心病外科

心脏术后心源性休克行VA-ECMO:90天死亡危险因素

Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-06-04

该回顾性研究纳入105例因难治性心脏术后心源性休克接受VA-ECMO支持的患者,分析VA-ECMO植入前变量与90天全因死亡的关系。90天总死亡率为57%,多因素分析显示动脉乳酸水平和缺血性心脏病是90天死亡的独立危险因素。

要点

  • 心脏术后心源性休克VA-ECMO患者90天死亡率为57%。
  • VA-ECMO前动脉乳酸升高与90天死亡独立相关。
  • 缺血性心脏病是90天死亡的独立危险因素。

核心结论

  • 在心脏术后心源性休克患者中,缺血性心脏病和VA-ECMO启动前动脉乳酸水平是90天死亡的独立危险因素。

研究设计与样本

  • 回顾性分析105例因难治性心脏术后心源性休克接受VA-ECMO支持的连续患者。
  • 采用单因素和多因素logistic回归分析植入前变量与90天全因死亡的关系。

主要发现

  • 主要手术亚组为单一非冠状动脉旁路移植术(29%)、孤立冠状动脉旁路移植术(20%)以及2项和3项同期手术(分别为31%和20%)。
  • 患者中位年龄62岁(四分位距52-68岁),男性占76%。
  • 30%的患者在VA-ECMO启动前接受了心肺复苏。
  • VA-ECMO中位持续时间为7天(四分位距3-14)。

关键数值与推荐

  • 多因素logistic回归显示动脉乳酸每单位 odds ratio 1.22(95%CI 1.07-14.0,P=.004)为90天死亡的独立危险因素。
  • 缺血性心脏病 odds ratio 7.87(95%CI 2.55-24.3,P<.001)为90天死亡的独立危险因素。

临床怎么用

  • VA-ECMO启动前可获取的动脉乳酸水平和缺血性心脏病病史可用于风险预测,可能改善这一资源密集型治疗的患者选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Refractory postcardiotomy cardiogenic shock is associated with a high mortality, and venoarterial extracorporeal membrane oxygenation can offer acute cardiopulmonary life support. The aim of this study was to identify pre-venoarterial extracorporeal membrane oxygenation risk factors of 90-day mortality. METHODS: We retrospectively analyzed 105 consecutive patients supported with venoarterial extracorporeal membrane oxygenation due to refractory postcardiotomy cardiogenic shock. The association between preimplant variables and all-cause mortality at 90 days was analyzed with univariable and multivariable logistic regression. RESULTS: Main surgical subgroups were single noncoronary artery bypass grafting (29%), isolated coronary artery bypass grafting (20%), and 2 and 3 concomitant surgical procedures (31% and 20%, respectively). The median age of patients was 62 years (interquartile range, 52-68 years), and 76% were men. Cardiopulmonary resuscitation was performed in 30% of patients before venoarterial extracorporeal membrane oxygenation initiation. The median duration of venoarterial extracorporeal membrane oxygenation was 7 days (interquartile range, 3-14). The 90-day overall mortality was 57%, and in-hospital mortality was 56%. Forty-seven percent of patients died on venoarterial extracorporeal membrane oxygenation, 51% of patients were successfully weaned, 1% of patients were bridged to heart transplantation, and 1% of patients were bridged to left ventricular assist device. Multivariable logistic regression analysis identified arterial lactate (odds ratio per unit, 1.22; 95% confidence interval, 1.07-14.0; P = .004) and ischemic heart disease (odds ratio, 7.87; 95% confidence interval, 2.55-24.3; P < .001) as independent risk factors of 90-day mortality. CONCLUSIONS: In patients with postcardiotomy cardiogenic shock, ischemic heart disease and level of arterial lactate before venoarterial extracorporeal membrane oxygenation initiation were identified as independent pre-venoarterial extracorporeal membrane oxygenation risk factors of 90-day mortality. These risk factors are easily available for pre-venoarterial extracorporeal membrane oxygenation risk prediction and may improve patient selection for this resource-intensive therapy.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Fux T, Holm M, Corbascio M, et al. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality. J Thorac Cardiovasc Surg. 2018. PMID: 30343699. doi:10.1016/j.jtcvs.2018.05.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。